Madhav Vissa, MD
Assistant Professor
Pediatrics
School of Medicine

I am a pediatric hematologist with a special interest in caring for individuals with inherited blood disorders, specifically sickle cell disease and thalassemia, throughout the lifespan. Before my fellowship training in pediatric hematology/oncology, I completed a residency in combined internal medicine and pediatrics with the goal of providing specialty care for individuals with lifelong medical conditions.

Show full bio (70 words) Hide full bio

My overarching goal is to ensure patients who live with chronic conditions are able to thrive as healthy, functional children, adolescents and adults. I aim to achieve this by providing excellent clinical care, engaging in clinical research to better understand the current state and future of care and care delivery, and continue to learn by teaching others about the complexities of these fascinating hematologic conditions.

Education & Training

Show all (4) Hide

• Fellowship Pediatric Hematology/Oncology UCSF Benioff Children's Hospital Oakland 06/2021
• Chief Residency Internal Medicine and Pediatrics University of Pittsburgh Medical Center 06/2018
• Internship and Residency Internal Medicine and Pediatrics University of Pittsburgh Medical Center 06/2018
• MD Medicine SUNY Downstate Medical Center 05/2014

Publications (6)

Top publication keywords:
HemePyrazolesErythrocyte TransfusionBenzaldehydesHemopexinTransplantation ConditioningHemoglobinsAnemia, Sickle CellPyrazinesHematopoietic Stem Cell TransplantationTransfusion ReactionReticulocytesTransplantation, AutologousHemolysisThrombotic Microangiopathies

• Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
  Experimental biology and medicine (Maywood, N.J.) 2023 Vissa M, Larkin SK, Vichinsky EP, Kuypers FA, Soupene E
• Voxelotor for the treatment of sickle cell disease.
  Expert review of hematology 2021 Vissa M, Vichinsky E
• A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
  Blood advances 2021 Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, Ingraham H, Higham C, Dvorak CC, Duncan C, Schoettler M, Lehmann L, Cancio M, Killinger J, Davila B, Phelan R, Mahadeo KM, Khazal S, Lalefar …
• Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT
• Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
  Pediatric blood & cancer 2017 Leeper CM, Vissa M, Cooper JD, Malec LM, Gaines BA
• Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
  Journal of pediatric hematology/oncology 2015 Blauel ER, Grossmann LT, Vissa M, Miller ST